Lovastatin and Niacin: Can You Take Them Together?

High: Consult Your DoctorConflict
Learn about each ingredient:LovastatinNiacin

Quick answer

Niacin taken at cholesterol-lowering amounts (1 gram a day or more) adds to lovastatin's risk of muscle injury (myopathy), including rare rhabdomyolysis, a severe breakdown of muscle that can harm the kidneys. The lovastatin label says to use caution with this combination because niacin can cause myopathy on its own, asks prescribers to weigh the benefit against the risk, and notes that in uncontrolled studies most patients who developed myopathy on lovastatin were also taking cyclosporine, gemfibrozil or niacin. The rate was measured with simvastatin, another statin: in a trial of 25,673 adults, adding extended-release niacin raised definite myopathy about 4-fold and did not reduce major vascular events. The small amounts of niacin in a multivitamin are not what the label describes.

Do not add niacin at cholesterol-lowering amounts to lovastatin unless your prescriber has decided the benefit outweighs the muscle risk and is following you. Report new muscle pain, tenderness, weakness or dark urine promptly, and check any B3 or cholesterol supplement with your doctor or pharmacist.

What happens?

Lovastatin can injure muscle, and cholesterol-dose niacin adds to that risk of myopathy and rare rhabdomyolysis.

1

Added muscle risk

Lovastatin can cause myopathy on its own, and the label says niacin at 1 gram a day or more can too, so the risks add up.

2

Two effects combined

The label groups niacin with drugs that are not strong blockers of the enzyme that clears lovastatin; the concern is two muscle effects adding up.

3

Rare kidney danger

In rare cases muscle injury becomes rhabdomyolysis, which releases muscle proteins that can harm the kidneys.

The lovastatin label warns about niacin at <strong>1 gram a day or more</strong>; with simvastatin, that kind of niacin raised definite myopathy about <strong>4-fold</strong>.

Why is this important?

This is an FDA label warning, and the size of the muscle risk was measured in one of the largest niacin trials ever run, with another statin.

Label warning

The lovastatin label says to use caution with lipid-lowering doses of niacin and to weigh the benefit against the risk.

Measured with another statin

With simvastatin, adding extended-release niacin raised definite myopathy about 4-fold (0.16 versus 0.04 percent a year).

No heart benefit to offset it

In two large trials of people on a statin, adding niacin did not reduce heart attacks, strokes or other major vascular events.

Large trials did not show a heart benefit from adding niacin to a statin, which is why the label asks prescribers to weigh the benefit against the muscle risk.

What should you do?

The practical fix is simple: separate the doses.

Treat cholesterol-dose niacin as a prescriber decision

Best practical schedule

Before starting niacin
Ask your prescriber before adding any niacin product sold for cholesterol, and mention if you are 65 or older or have kidney problems.
Every day on both
If your prescriber chose the combination, take both as prescribed and notice any new muscle symptoms, especially early on and after dose increases.
If symptoms appear
Call your doctor about unexplained muscle pain, tenderness, weakness or dark urine; your doctor may check your CK level.

Important reminders

  • •The warning is about niacin at 1 gram a day or more, not multivitamin amounts.
  • •Niacinamide is a different form of vitamin B3 and is not what the warning describes.
  • •Slow-release niacin still raised muscle problems in the large simvastatin trial.
  • •Never stop or change lovastatin on your own; talk to your doctor first.

Because adding niacin to a statin did not reduce heart attacks or strokes in large trials, your prescriber may suggest a different approach if your cholesterol needs more lowering.

Which specific products are affected?

Many common Niacin products can affect this interaction.

Lovastatin products this applies to

Generic lovastatin tabletsAdvicor (niacin extended-release and lovastatin, an older combined tablet)

Niacin products at cholesterol-lowering amounts

Niaspan and generic extended-release niacinImmediate-release niacin (nicotinic acid)High-strength over-the-counter niacin sold for cholesterolSlow-release or sustained-release niacin supplements

Other sources

  • •Standard multivitamins and B-complex products contain far less niacin than the 1 gram a day the warning describes.
  • •Niacinamide (nicotinamide) is a different form of vitamin B3 and is not used to lower cholesterol.

Read the Supplement Facts label for the form of vitamin B3 and the amount per serving, and ask your pharmacist if a product is sold for cholesterol.

The bottom line

Niacin at cholesterol-lowering amounts adds to lovastatin's risk of muscle injury, and in rare cases rhabdomyolysis. The lovastatin label says to use caution with lipid-lowering doses of niacin (1 gram a day or more) because niacin can cause myopathy on its own, and to weigh the benefit against the risk. With simvastatin, a large trial found adding niacin raised definite myopathy about 4-fold without lowering major vascular events.

Multivitamin amounts of niacin, and niacinamide, are not what this warning is about.

What happens when you take lovastatin with niacin?

Lovastatin is a statin that lowers LDL cholesterol. Niacin (nicotinic acid) is vitamin B3. In large amounts, 1 gram a day or more, niacin is also used to change blood fats, either as a prescription (such as Niaspan) or as a high-strength supplement. Lovastatin can injure muscle, and niacin at those amounts can do the same, so together the risk adds up.

  1. Lovastatin can cause myopathy: muscle pain, tenderness or weakness with a large rise in the muscle enzyme creatine kinase (CK).
  2. The lovastatin label lists niacin at 1 gram a day or more among lipid-lowering drugs that raise the risk of myopathy because they can cause it on their own.
  3. The label groups niacin with lipid-lowering drugs that are not strong CYP3A4 blockers. The concern is two muscle effects adding together, not a higher lovastatin level.
  4. In rare cases muscle injury becomes rhabdomyolysis, where damaged muscle releases proteins that can harm the kidneys. The label says rare deaths have occurred with lovastatin.
  5. The label adds that in uncontrolled clinical studies, most patients who developed myopathy were also taking cyclosporine, gemfibrozil or niacin.

Why is this important?

This is a label warning, not a theory. The lovastatin label tells prescribers to use caution with lipid-lowering doses of niacin and to weigh the benefit of further changes in blood fats against the risks of the combination.

The size of the risk has not been measured with lovastatin itself. It was measured with simvastatin, another statin: in the HPS2-THRIVE trial, adding extended-release niacin raised definite myopathy about 4-fold, and muscle problems were more common in participants in China.

The extra risk also comes without a proven heart benefit. In two large trials of people already on a statin (simvastatin), adding niacin did not reduce heart attacks, strokes or other major vascular events. The lovastatin label also names age 65 or older and kidney problems as factors that call for extra care, which is why the decision belongs to your prescriber.

What should you do?

The principle is simple: cholesterol-dose niacin is a medicine decision, not a supplement add-on, when you take lovastatin.

Before starting niacin: If you take lovastatin and are thinking about a high-strength niacin product for cholesterol, talk to your prescriber first. Mention if you are 65 or older or have kidney problems.

Every day while on both: If your prescriber has decided the combination is right for you, take both exactly as prescribed and pay attention to your muscles, especially in the first weeks and after a dose increase of either one.

If symptoms appear: Contact your doctor promptly about unexplained muscle pain, tenderness or weakness, especially with fever, tiredness or dark urine. Do not stop or change lovastatin on your own; your doctor may check your CK level and decide what to change.

Which specific products are affected?

On the medication side, this applies to generic lovastatin tablets. Advicor, an older tablet that combined extended-release niacin with lovastatin in one pill, already contains both.

On the niacin side, the label warning is about niacin (nicotinic acid) at 1 gram a day or more. That includes prescription extended-release niacin (Niaspan and generics), immediate-release niacin, and high-strength over-the-counter niacin sold for cholesterol. The small amounts of niacin in a standard multivitamin or B-complex are far below that level. Niacinamide (nicotinamide), a different form of vitamin B3 found in many multivitamins and skin products, is not used to lower cholesterol and is not the form the label describes. Read the Supplement Facts label for the form and the amount per serving.

The science behind it

The lovastatin tablets prescribing information on DailyMed (Warnings, Myopathy/Rhabdomyolysis) says caution should be used when prescribing lipid-lowering doses of niacin (1 gram a day or more) with lovastatin, as these agents can cause myopathy when given alone, and that the benefit of further changes in lipid levels should be carefully weighed against the potential risks. Its Precautions section lists niacin among lipid-lowering drugs that are not strong CYP3A4 inhibitors but raise myopathy risk, and its Adverse Reactions section notes that in uncontrolled clinical studies most patients who developed myopathy were receiving cyclosporine, gemfibrozil or niacin.

The best measured rate comes from a different statin. In HPS2-THRIVE, 25,673 adults with vascular disease on simvastatin were randomized to extended-release niacin with laropiprant or placebo. Definite myopathy occurred in 75 people on niacin versus 17 on placebo (risk ratio 4.4), and any myopathy was more common in China (HPS2-THRIVE Collaborative Group, Eur Heart J 2013, PMID 23444397). Major vascular events did not fall (13.2 versus 13.7 percent) (N Engl J Med 2014, PMID 25014686), and in AIM-HIGH, adding niacin to simvastatin gave no extra benefit (N Engl J Med 2011, PMID 22085343).

Lovastatin and extended-release niacin were also studied together as a combined tablet. In a 52-week open-label study of 814 adults, no drug-induced myopathy occurred (Kashyap ML, et al. Am J Cardiol 2002, PMID 11897208), and an analysis of FDA adverse event reports from 1999 to 2005 found rhabdomyolysis reports for the combined tablet at rates similar to other statins or niacin alone (Alsheikh-Ali AA, Karas RH. Am J Cardiol 2007, PMID 17261402). A study of this size cannot rule out a rare muscle injury, and spontaneous reports cannot give a true rate. What was not shown: no randomized trial has measured the myopathy rate of niacin with lovastatin specifically, and the warning does not cover multivitamin amounts.

Frequently Asked Questions

Is the niacin in my multivitamin a problem with lovastatin?

The label warning is about niacin at 1 gram a day or more. Multivitamins contain far less. If you are unsure about a product, show the label to your pharmacist.

Why would anyone take niacin with a statin?

Niacin raises HDL cholesterol and lowers triglycerides, so it was once added to statins, and a combined niacin and lovastatin tablet was sold. In large trials, adding niacin to a statin did not reduce heart attacks or strokes and raised side effects, so it is now used far less.

Does slow-release or flush-free niacin avoid the problem?

Slow-release niacin does not: the large trial that measured the muscle risk used an extended-release form. Products sold as flush-free were not tested. Ask your pharmacist what form of niacin a product contains and how much.

Does niacin raise my lovastatin level?

The label does not describe that. It groups niacin with lipid-lowering drugs that are not strong CYP3A4 blockers; the concern is that niacin can harm muscle on its own, adding to lovastatin's effect.

What muscle symptoms should I watch for?

Unexplained muscle pain, tenderness or weakness, especially with fever, feeling unwell or dark urine. Contact your doctor promptly rather than waiting.

Is niacinamide the same as niacin?

No. Niacinamide is another form of vitamin B3 that is not used to lower cholesterol and is not the form the label warning describes.

Key takeaways

  • Niacin at cholesterol-lowering amounts (1 gram a day or more) raises the risk of muscle injury with lovastatin, according to the lovastatin label.
  • The label asks prescribers to use caution and weigh the benefit, because niacin can cause myopathy on its own.
  • With simvastatin, adding extended-release niacin raised definite myopathy about 4-fold without reducing major vascular events.
  • Multivitamin amounts of niacin, and niacinamide, are not what the warning is about.
  • Report new muscle pain, weakness or dark urine promptly, and never change lovastatin on your own.

References

Primary evidence for this article. Always consult your healthcare provider for personal medical advice.

Related Interactions

Other interactions you should know about

Atorvastatin + Niacin

high

Adding cholesterol-dose niacin to atorvastatin raises the risk of muscle injury (myopathy, rarely rhabdomyolysis) without improving cardiovascular outcomes in patients already well treated with a statin.

Gemfibrozil + Red Yeast Rice

high

Red yeast rice supplies monacolin K, a compound chemically identical to the statin lovastatin. Combining it with gemfibrozil, a fibrate, can add up to serious muscle injury. The fibrate is itself toxic to muscle and also raises circulating statin levels by interfering with how the statin is cleared, so the two effects stack toward myopathy and, in the worst case, rhabdomyolysis with kidney injury.

Niacin + Red Yeast Rice

moderate

Red yeast rice contains monacolin K, which is chemically identical to the statin lovastatin, so it behaves as a low-dose statin. Lipid-modifying amounts of niacin can independently injure skeletal muscle, and combining a lovastatin-class agent with such niacin can add to the risk of muscle pain or damage (including, rarely, rhabdomyolysis). Because red yeast rice acts as a variable-strength statin, the same additive muscle-toxicity concern applies when it is taken alongside high-dose niacin.

Ketoconazole + Red Yeast Rice

high

Oral ketoconazole tablets strongly block CYP3A4, the enzyme that breaks down lovastatin. Red yeast rice's monacolin K is the same molecule as lovastatin, and both the ketoconazole tablet label and the lovastatin label contraindicate lovastatin with ketoconazole because higher statin levels raise the risk of muscle injury, including rhabdomyolysis. Red yeast rice itself has not been studied with ketoconazole, and products vary widely in how much monacolin K they contain. Ketoconazole creams and shampoos are not covered by the tablet label's warnings.

Simvastatin + Red Yeast Rice

high

Red yeast rice contains monacolin K, which is chemically identical to the prescription statin lovastatin. Adding it to simvastatin stacks two statins with the same mechanism and metabolism, adding to the risk of muscle injury, rhabdomyolysis, and liver problems.

Cbd + Simvastatin

low

Simvastatin is cleared mainly by the liver enzyme CYP3A4, and CBD inhibits that same enzyme in laboratory studies. Combining them could raise simvastatin exposure, which could increase the risk of muscle pain and, rarely, more serious muscle injury. This is a predicted interaction, not a confirmed one: the Epidiolex label reports that CBD did not change levels of midazolam, a sensitive CYP3A4 drug, and we found no human study of CBD with simvastatin.

Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before making changes to your supplement or medication routine. Pilora does not diagnose, treat, cure, or prevent any disease.

Check all your supplement interactions instantly

Try Pilora Free